RESUMEN
BACKGROUND AND AIMS: Smoking affects the course of inflammatory bowel disease [IBD]. We aimed to study the impact of smoking on IBD-specific costs and health-related quality-of-life [HrQoL] among adults with Crohn's disease [CD] and ulcerative colitis [UC]. METHODS: A large cohort of IBD patients was prospectively followed during 1 year using 3-monthly questionnaires on smoking status, health resources, disease activity and HrQoL. Costs were calculated by multiplying used resources with corresponding unit prices. Healthcare costs, patient costs, productivity losses, disease course items and HrQoL were compared between smokers, never-smokers and ex-smokers, adjusted for potential confounders. RESULTS: In total, 3030 patients [1558 CD, 1054 UC, 418 IBD-unknown] were enrolled; 16% smoked at baseline. In CD, disease course was more severe among smokers. Smoking was associated with > 30% higher annual societal costs in IBD (7,905 [95% confidence interval 6,234 - 9,864] vs 6,017 [5,186 - 6,946] in never-smokers and 5,710 [4,687 - 6,878] in ex-smokers, p = 0.06 and p = 0.04, respectively). In CD, smoking patients generated the highest societal costs, primarily driven by the use of anti-tumour necrosis factor compounds. In UC, societal costs of smoking patients were comparable to those of non-smokers. Societal costs of IBD patients who quitted smoking > 5 years before inclusion were lower than in patients who quitted within the past 5 years ( 5,135 [95% CI 4,122 - 6,303] vs 9,342 [6,010 - 12,788], p = 0.01). In both CD and UC, smoking was associated with a lower HrQoL. CONCLUSIONS: Smoking is associated with higher societal costs and lower HrQoL in IBD patients. Smoking cessation may result in considerably lower societal costs.
Asunto(s)
Colitis Ulcerosa/economía , Colitis Ulcerosa/epidemiología , Costo de Enfermedad , Enfermedad de Crohn/economía , Enfermedad de Crohn/epidemiología , Costos de la Atención en Salud , Calidad de Vida , Fumar/economía , Fumar/epidemiología , Adulto , Anciano , Colitis Ulcerosa/tratamiento farmacológico , Comorbilidad , Enfermedad de Crohn/tratamiento farmacológico , Eficiencia , Empleo/estadística & datos numéricos , Femenino , Recursos en Salud/economía , Recursos en Salud/estadística & datos numéricos , Humanos , Masculino , Persona de Mediana Edad , Países Bajos/epidemiología , Estudios Prospectivos , Índice de Severidad de la Enfermedad , Cese del Hábito de Fumar/economía , Encuestas y Cuestionarios , Brote de los SíntomasRESUMEN
BACKGROUND AND AIMS: Smoking affects the course of disease in patients with ulcerative colitis (UC) and Crohn's disease (CD). We aimed to study the association between smoking and extra-intestinal manifestations (EIMs) in inflammatory bowel disease (IBD). METHODS: We cross-sectionally explored the association between smoking and EIMs in IBD in three cohort studies: (1) the COIN study, designed to estimate healthcare expenditures in IBD; (2) the Groningen study, focused on cigarette smoke exposure and disease behaviour in IBD; and (3) the JOINT study, evaluating joint and back manifestations in IBD. RESULTS: In the COIN, Groningen and JOINT cohorts, 3030, 797 and 225 patients were enrolled, of whom 16, 24 and 23.5% were current smokers, respectively. Chronic skin disorders and joint manifestations were more prevalent in smoking IBD patients than in non-smokers (COIN, 39.1 vs 29.8%, p <0.01; Groningen, 41.7 vs 30.0%, p <0.01) in both CD and UC. In the JOINT cohort, smoking was more prevalent in IBD patients with joint manifestations than in those without (30.3 vs 13.0%, p <0.01). EIMs appeared to be more prevalent in high- than in low-exposure smokers (56.0 vs 37.1%, p = 0.10). After smoking cessation, the prevalence of EIMs in IBD patients rapidly decreased towards levels found in never smokers (lag time: COIN cohort, 1-2 years; Groningen cohort, within 1 year). CONCLUSIONS: There is a robust dose-dependent association between active smoking and EIMs in both CD and UC patients. Smoking cessation was found to result in a rapid reduction of EIM prevalence to levels encountered in never smokers.
Asunto(s)
Enfermedades Inflamatorias del Intestino/complicaciones , Fumar/efectos adversos , Adulto , Artritis/etiología , Colitis Ulcerosa/complicaciones , Colitis Ulcerosa/etiología , Colitis Ulcerosa/patología , Enfermedad de Crohn/complicaciones , Enfermedad de Crohn/etiología , Enfermedad de Crohn/patología , Estudios Transversales , Femenino , Humanos , Enfermedades Inflamatorias del Intestino/etiología , Enfermedades Inflamatorias del Intestino/patología , Masculino , Persona de Mediana Edad , Enfermedades de la Piel/etiología , Cese del Hábito de FumarRESUMEN
Sediment samples from the Karnaphuli river estuary, nearshore, and off-shore regions off the coast of Chittagong in the Bay of Bengal were analyzed for the natural radioactivity contents of 232Th, 238U and 40K and anthropogenic radioactivity contents of 137Cs and 134Cs using HPGe gamma spectrometry, together with the measurement of sediment pH and grain size analyses of the collected samples. The activity of 232Th found in sediment ranged from 10.44 +/- 2.31 to 64.02 +/- 8.13 Bq kg(-1), 238U activity ranged from 5.87 +/- 1.21 to 27.85 +/- 1.71 Bq kg(-1), 40K activity from 118.28 +/- 19.70 to 608.21 +/- 75.70 Bq kg(-1), and the activity 137Cs ranged from 0.09 +/- 0.06 to 4.64 +/- 0.19 Bq kg(-1), no 134Cs radioactivity was detected at any of the sampling stations.